543595 — EP Biocomposites Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹168.07m
- IN₹196.21m
- IN₹120.06m
- 60
- 53
- 14
- 35
Annual cashflow statement for EP Biocomposites, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4.64 | 11.7 | 8.14 | 15.7 | 14.2 |
| Depreciation | |||||
| Non-Cash Items | -0.043 | 2.93 | 0.58 | -0.735 | 3.44 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.27 | -58.2 | -17.7 | -28.4 | -23.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.331 | -42.9 | -7.94 | -12.4 | -4.9 |
| Capital Expenditures | -0.027 | -4.74 | -0.224 | -2.36 | -0.214 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.043 | 0.159 | 0.448 | 0.728 | 0.371 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.016 | -4.58 | 0.224 | -1.63 | 0.157 |
| Financing Cash Flow Items | 0 | -1.56 | -7.13 | -0.349 | -3.55 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.025 | 47.6 | 28.1 | 4.86 | 8.21 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.322 | 0.081 | 20.4 | -9.22 | 3.47 |